Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
MA02 - Miscellaneous Topics in the Management of Early Stage Lung Cancer
- 10:30 - 12:00
- 9/08/2019
- Location: Interlaken (1988)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Treatment of Early Stage/Localized Disease
- Moderators:Mireia Serra-Mitjans, Thomas A. D'Amico
-
+
MA02.07 - A Phase I Trial of an Immune Checkpoint Inhibitor Plus Stereotactic Ablative Radiotherapy in Patients with Early Stage Non-Small Cell Lung Cancer
11:10 - 11:15 | Presenter: Megan Eileen Daly | Author(s): Arta Monir Monjazeb, Amin Mirhadi, David Eastham, Frances Lara, Jonathan Wesley Riess, Ellen A Wiegner, Karen Kelly
- Abstract
Loading...
-
+
OA04 - Immuno Combinations and the Role of TMB
- 15:15 - 16:45
- 9/08/2019
- Location: Copenhagen (1980)
- IASLC CME Accredited
- Type: Oral Session
- Track: Immuno-oncology
- Moderators:Solange Peters, Martin Reck
-
+
OA04.01 - A Phase III Randomized Study of Nivolumab/Ipilimumab vs Nivolumab for Previously Treated Stage IV Squamous Cell Lung Cancer
15:15 - 15:25 | Presenter: Lyudmila Bazhenova | Author(s): Mary Redman, Scott Gettinger, Fred R. Hirsch, Philip Mack, Lawrence H Schwartz, David R Gandara, Jeffrey D Bradley, Thomas Stinchcombe, Natasha B Leighl, Suresh S Ramalingam, Susan Tavernier, Katherine Minichiello, Karen Kelly, Vassiliki A Papadimitrakopoulou, Roy S. Herbst
- Abstract
Loading...
-
+
OA07 - Precision Medicine Involves Biology and Patients
- 11:00 - 12:30
- 9/09/2019
- Location: Copenhagen (1980)
- IASLC CME Accredited
- Type: Oral Session
- Track: Advanced NSCLC
- Moderators:Silvia Novello, Fabrice Barlesi
-
+
OA07.06 - Patient Knowledge and Expectations Related to Return of Genomic Results in the Lung-MAP (SWOG 1400) Biomarker-Driven Clinical Trial
11:50 - 12:00 | Presenter: Joshua A Roth | Author(s): Meghna S Trivedi, Stacy Gray, Donald Patrick, Wylie Burke, Debbie Delaney, Kate Watabayashi, Paul Litwin, Parth Shah, Katherine D. Crew, Monica Yee, Mary Redman, Vassiliki A Papadimitrakopoulou, Karen Kelly, David R Gandara, Dawn L Hershman, Scott D Ramsey
- Abstract
Loading...
-
+
MA14 - The Adequate MTarget Is Still the Issue
- 15:45 - 17:15
- 9/09/2019
- Location: Hilton Head (1978)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Advanced NSCLC
- Moderators:Diego Signorelli, Juergen Wolf
-
+
MA14.03 - EGFR M+ Subgroup of Phase 1b Study of Telisotuzumab Vedotin (Teliso-V) Plus Erlotinib in c-Met+ Non-Small Cell Lung Cancer
15:55 - 16:00 | Presenter: D. Ross Camidge | Author(s): Fabrice Barlesi, Jonathan Goldman, Daniel Morgensztern, Rebecca S Heist, Everett E. Vokes, Alex Spira, Eric Angevin, Wu-Chou Su, David S. Hong, John H. Strickler, Monica Motwani, Zhaowen Sun, Apurvasena Parikh, Philip Komarnitsky, Jun Wu, Karen Kelly
- Abstract
Loading...
-
+
MA25 - Precision Medicine in Advanced NSCLC
- 14:30 - 16:00
- 9/10/2019
- Location: Dublin (1997)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Advanced NSCLC
- Moderators:Sebastian Defranchi, Karen Kelly
-
+
MA25.01 - Pembrolizumab Plus Chemotherapy for Advanced NSCLC Without Tumor PD-L1 Expression: Pooled Analysis of KN021G, KN189 and KN407
14:30 - 14:37 | Presenter: Hossein Borghaei | Author(s): Corey Jay Langer, Luis Paz-Ares, Delvys Rodriguez Abreu, Balazs Halmos, Vassiliki A Papadimitrakopoulou, Marina Chiara Garassino, Baerin Houghton, Takayasu Kurata, Ying Cheng, Jianxin Lin, M. Catherine Pietanza, Bilal Piperdi, Shirish Gadgeel
- Abstract
Loading... -
+
MA25.02 - Arrangement and Architecture of Tumor-Infiltrating Lymphocyte on H&E Slides Predict OS in Nivolumab Treated Non-Small Cell Lung Cancer
14:37 - 14:44 | Presenter: Kaustav Bera | Author(s): Xiangxue Wang, Cristian Barrera, Cheng Lu, Michael Feldman, Kurt A Schalper, David Rimm, Vamsidhar Velcheti, Anant Madabhushi
- Abstract
Loading... -
+
MA25.03 - Tumor-Infiltrating Lymphocytes (TIL) and Outcomes with Immunotherapy (ICI) or Chemotherapy in Advanced NSCLC (aNSCLC) Patients
14:44 - 14:51 | Presenter: Julien Adam | Author(s): Laura Mezquita, Ithar Gataa, Caroline Rossoni, Edouard Auclin, Myriam Kossai, Frank Aboubakar, Sylvestre Le Moulec, Julie Massé, Morgane Masson, Nina Radosevic-Robin, Mathieu Rouanne, Maria Virginia Bluthgen, CAROLINE Caramella, Lizza Hendriks, Anas Gazzah, David Planchard, Jean-Pierre Pignon, Benjamin Besse
- Abstract
Loading... -
+
MA25.04 - Blood-Based Tumor Mutation Burden as a Predictive Biomarker for Outcomes After Pembrolizumab Based First Line Therapy in Metastatic NSCLC
14:51 - 14:58 | Presenter: Charu Aggarwal | Author(s): Jeffrey C Thompson, Austin Chien, Katie Quinn, Martina I. Lefterova, Rebecca Nagy, Stephanie S Yee, Michael Lariviere, Christine Ciunci, Aditi Singh, Joshua M Bauml, Roger B Cohen, Corey Jay Langer, Erica Carpenter
- Abstract
Loading... -
+
MA25.05 - Discussant - MA25.01, MA25.02, MA25.03, MA25.04
14:58 - 15:08 | Presenter: Karen Kelly
- Abstract
No abstract available for this presentation
-
+
MA25.06 - Q&A Session
15:08 - 15:15
- Abstract
No abstract available for this presentation
-
+
MA25.07 - Genomic Profiling of Lung Adenocarcinoma by Targeted NGS Using Extracellular Vesicle-Derived DNA in Bronchoalveolar Lavage Fluid
15:15 - 15:22 | Presenter: Seungeun Lee | Author(s): Kye Young Lee, Jae Young Hur, Heejoung Kim, Wan Seop Kim, In Ae Kim, Ha Young Park
- Abstract
Loading... -
+
MA25.08 - Characterisation of Tumor Aetiology Using Mutational Signatures from the Non-Small Cell Lung Cancer Genome
15:22 - 15:29 | Presenter: Colin Lindsay | Author(s): Shereen Rafee, Pantelis Nicola, Andrew Wallace, George Burghel, Helene Schlecht, Katie Baker, Eleanor Baker, Lynsey Priest, Jane Rogan, Sharzad Moghadam, Mat Carter, William Newman, Fiona Blackhall
- Abstract
Loading... -
+
MA25.09 - Navigating Anlotinib Precision Therapy Through the Genetic Profiling of Circulating DNA in Non-Small Cell Lung Cancer Patients
15:29 - 15:36 | Presenter: Jun Lu | Author(s): Hua Zhong, Jun Wu, Tianqing Chu, Lele Zhang, Hua Li, Qiming Wang, Rong Li, Yizhuo Zhao, Aiqin Gu, Chunlei Shi, Liwen Xiong, Xueyan Zhang, Wei Zhang, Yuqing Lou, Bo Yan, Yu Dong, Yanwei Zhang, Baolan Li, Li Zhang, Xiaodong Zhao, Kai Li, Baohui Han
- Abstract
Loading... -
+
MA25.10 - First-In-Human Phase 1 Study of DS-1062a (TROP2 Antibody-Drug Conjugate) in Patients with Advanced Non-Small Cell Lung Cancer
15:36 - 15:43 | Presenter: Rebecca S Heist | Author(s): Jacob Sands, Toshio Shimizu, Edward Garon, Antoine Yver, Jonathan Greenberg, Penny Phillips, Yukata Noguchi, Alexander Spira, Noboru Yamamoto, Melissa Johnson, Funda Meric-Bernstam, Kiyotaka Yoh, Aaron Lisberg
- Abstract
Loading... -
+
MA25.11 - Discussant - MA25.07, MA25.08, MA25.09, MA25.10
15:43 - 15:53 | Presenter: Sebastian Defranchi
- Abstract
No abstract available for this presentation
-
+
MA25.12 - Q&A Session
15:53 - 16:00
- Abstract
No abstract available for this presentation